Asia-Pacific Bacteriophages Therapy Market to 2032
Overview
The Asia-Pacific Bacteriophages Therapy Market is expected to reach a 17.48 USD Million by 2032 and is projected to grow at a CAGR of 11.34% from 2025 to 2032.
Revenue, 2024 (USD Million)
9.87
Forecast, 2032 (USD Million)
17.48
CAGR, 2024 - 2032
11.34%
Report Coverage
Asia-Pacific
Asia-Pacific Bacteriophages Therapy Market 2018-2032 USD Million
Asia-Pacific Bacteriophages Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 9.87 USD Million
- Projected Market Size (2032): 17.48 USD Million
- CAGR (2025-2032): 11.34%
Key Findings of Asia-Pacific Bacteriophages Therapy Market
- The Asia-Pacific Bacteriophages Therapy Market was valued at 9.87 USD Million in 2024.
- The Asia-Pacific Bacteriophages Therapy Market is likely to grow at a CAGR of 11.34% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 9.10 USD Million
- The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 12.05% during the forecast period from 2024 to 2032.
Asia-Pacific Bacteriophages Therapy Market Scope
Asia-Pacific Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Type
- Lysogenic
- Lytic
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Asia-Pacific Bacteriophages Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 9.87 USD Million |
| Market Value in 2032 | 17.48 USD Million |
| CAGR (2025-2032) | 11.34% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Target,Type,End User,Route Of Administration,Application,Base |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 9.87 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 3.16 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 8.99 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 11.49 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 2.58 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 10.95 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 9.10 USD Million in the year 2024.
- Lytic is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 11.48 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 3.61 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 10.94 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 4.19 USD Million in the year 2024.
- Dermal is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 10.94 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 3.16 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 11.87 % in forecast period 2025-2032.
-
Asia-Pacific Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a revenue of 6.98 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in Asia-Pacific Bacteriophages Therapy Market to 2032 with a Growth rate of 11.55 % in forecast period 2025-2032.
Asia-Pacific Bacteriophages Therapy Market Company Share Analysis
| Company Name |
|
||
| Microgen | |||
| MICREOS | |||
| Intralytix, Inc. | |||
| LOCUS BIOSCIENCES, INC. | |||
| Phagelux, Inc. | |||
Asia-Pacific Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Bacteriophages Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,Target,Type,End User,Route Of Administration,Application,Base.
Asia-Pacific Bacteriophages Therapy Market was valued at USD 9.87(Revenue in USD Million) in 2020.
Asia-Pacific Bacteriophages Therapy Market is projected to grow at a CAGR of 11.34% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the Asia-Pacific Bacteriophages Therapy Market, holding a largest market share of 9.10 USD Million in 2024
Asia-Pacific Bacteriophages Therapy Market Scope
Asia-Pacific Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Type
- Lysogenic
- Lytic
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Frequently Asked Questions
The Asia-Pacific Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,Target,Type,End User,Route Of Administration,Application,Base.
Asia-Pacific Bacteriophages Therapy Market was valued at USD 9.87(Revenue in USD Million) in 2020.
Asia-Pacific Bacteriophages Therapy Market is projected to grow at a CAGR of 11.34% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Bacteriophages Therapy Market for final year is USD 17.48 (USD Million).
Asia-Pacific Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,Target,Type,End User,Route Of Administration,Application,Base.
Asia-Pacific Bacteriophages Therapy Market was valued at USD 9.87(Revenue in USD Million) in 2020.
Asia-Pacific Bacteriophages Therapy Market is projected to grow at a CAGR of 11.34% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Bacteriophages Therapy Market for final year is USD 17.48 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.